# Evidence Accumulation Forecast Review 001

Objective: estimate how quickly AEGIS can accumulate statistically useful outcome evidence under current behavior.

Scope: existing evidence only. This review does not change exit rules, sleeves, candidate generation, governance, architecture, runtime truth logic, or trading behavior.

## Forecast

AEGIS is accumulating outcome evidence, but the rate is uneven and concentrated. The clearest historical sequence is:

- 2026-06-01: 57 paper positions, 2 closed outcomes, 2 included validation samples.
- 2026-06-02: 62 paper positions, 5 closed outcomes, 5 included validation samples.
- 2026-06-03: 63 paper positions, 12 closed outcomes, 12 included validation samples.
- 2026-06-04: 63 paper positions, 5 closed outcomes, 5 included validation samples, with sleeve performance truth blocked by missing paper_position_events authority.

The useful rate through 2026-06-03 was +10 included samples over two daily steps, or about +5 included validation samples per day during that short window. That rate should not be treated as stable. It came almost entirely from one sleeve and one hypothesis.

The near-term forecast from the 2026-06-03 open-position review is more conservative:

- 41 open C2_TREND_EQ_PRIMARY_V1 positions existed.
- 2 positions were within 1 percentage point of the existing stop-loss threshold.
- 0 positions were within 1 percentage point of the take-profit threshold.
- 0 positions were within 3 days of the max-hold threshold.
- All 41 positions had HOLD recommendations with NO_EXIT_RULE_TRIGGERED.

Forecast under current behavior:

- Near term: 0 to 2 additional validation samples appear plausible from the closest C2_TREND_EQ_PRIMARY_V1 positions if existing deterministic thresholds are reached.
- Short horizon: 2 to 10 additional samples are plausible if more of the 41 trend-equity open positions naturally cross existing deterministic exits.
- Medium horizon: evidence can become moderately informative for C2_TREND_EQ_PRIMARY_V1 if the current 12 usable samples grow toward roughly 20 to 30 closed samples, but this would still be sleeve-concentrated.
- Capital-review relevant: not forecastable from count alone under current evidence. Current artifacts show 0 validated hypotheses and 0 ready for capital review, so capital-review relevance requires more than additional sample count: distribution, robustness, benchmark evaluation, and quality improvement would also need to clear.

## Bottleneck Ranking

1. Time to deterministic closure.

Evidence strength: HIGH.

Most existing paper positions remain open. On 2026-06-03, validation samples had 51 excluded samples and outcome registry had 51 open outcomes. The C2 trend open-position review found 39 of 41 trend-equity open positions were not near stop-loss, take-profit, or max-hold closure thresholds.

2. Paper-position and outcome concentration.

Evidence strength: HIGH.

All 12 usable samples on 2026-06-03 came from HYP_LARGE_CAP_EQUITY_MOMENTUM_20_60D_V1 / C2_TREND_EQ_PRIMARY_V1. Other hypotheses had 0 usable validation samples.

3. Candidate conversion to paper observation.

Evidence strength: HIGH.

Candidate diagnostics and prior reviews show raw activity does not reliably become outcome evidence. HYP_EVENT_DISLOCATION_REPRICING_V1 had 23 candidates but 0 paper positions and 0 usable validation samples. Candidate generation diagnostics showed 42 raw signals, 1 generated candidate, and 1 paper position on 2026-06-03.

4. Paper-position depth outside the trend-equity sleeve.

Evidence strength: MEDIUM-HIGH.

Other paper-active sleeves had open paper positions but very low depth: C2_CROSS_ASSET_TREND_V1 had 5 open positions, C2_MEAN_REVERSION_EQ_V1 had 2, C2_VOL_INCOME_DEFINED_RISK_V1 had 2, and C2_OIL_SHOCK_REVERSAL_V1 had 1. These can produce first samples, but not many near-term samples.

5. Data and authority blockers.

Evidence strength: MEDIUM.

The 2026-06-04 sleeve performance truth was BLOCKED with missing paper_position_events authority for evaluated sleeves. This does not explain the 2026-06-03 included-sample count, but it can interrupt accumulation and interpretation.

6. Sleeve inactivity or no paper path.

Evidence strength: MEDIUM.

Decision artifacts classify several hypotheses as REDESIGN or NEEDS_DATA, with NO_CANDIDATE_FLOW, NO_OBSERVATION_FLOW, NO_PAPER_PATH, IMPLEMENTATION_INCOMPLETE_OR_NO_PAPER_PATH, and DATA_QUALITY_BLOCKED. These sleeves are unlikely to add outcomes soon under current behavior.

## Estimated Evidence Trajectory

UNDERPOWERED:

Current state. On 2026-06-03, statistical sufficiency showed 9 hypotheses, 8 underpowered, 1 validation-ready, and 0 validated. Research quality showed 10 hypotheses, 6 underpowered, 4 blocked, and 0 ready for capital review.

Expected duration under current behavior: still active after the next few outcome cycles unless many open C2_TREND_EQ_PRIMARY_V1 positions close. The near-term open-position review found only 2 positions close to deterministic closure.

MODERATELY INFORMATIVE:

Likely first reached by C2_TREND_EQ_PRIMARY_V1 only. A practical evidence-improvement band is roughly 20 to 30 usable closed samples for the same sleeve and hypothesis, because that would move beyond the current 12-sample early read while remaining far from broad validation.

Estimated path:
- Current usable samples: 12.
- Minimum additional samples for a materially better early read: about +8, reaching roughly 20.
- Stronger moderate read: about +18, reaching roughly 30.

Estimated timing:
- If the observed 2026-06-01 to 2026-06-03 burst rate repeated, this could happen in a few days.
- If only the two closest 2026-06-03 open positions close near term, the sample count would reach about 14 and remain underpowered.
- The conservative forecast is one to several outcome cycles for a modest improvement, and longer for moderate informativeness.

CAPITAL-REVIEW RELEVANT:

Not currently forecastable from sample count alone. The reviewed artifacts show 0 ready for capital review, 0 validated hypotheses, and early weak trend-equity evidence. Capital-review relevance would require:

- More closed samples.
- Less concentration in one sleeve and one hypothesis.
- Robustness and sample-independence improvement.
- Benchmark-relative evidence becoming evaluable.
- Evidence quality improving rather than merely accumulating more weak outcomes.

Under current behavior, capital-review relevance should be treated as not near term.

## Likely Outcome Contributors

1. C2_TREND_EQ_PRIMARY_V1.

Most likely contributor. It has 41 open positions on 2026-06-03, 12 closed positions, 12 usable validation samples, certified marks, and functioning deterministic exits. Two positions were closest to existing stop-loss closure.

2. C2_CROSS_ASSET_TREND_V1.

Potential contributor to distribution. It had 5 open paper positions and data quality PASS on 2026-06-03, but 0 closed positions and ZERO_SAMPLE evidence status.

3. C2_MEAN_REVERSION_EQ_V1.

Small contributor. It had 2 open paper positions, data quality PASS, and ZERO_SAMPLE status.

4. C2_VOL_INCOME_DEFINED_RISK_V1.

Small contributor. It had 2 open paper positions, data quality PASS, and ZERO_SAMPLE status.

5. C2_OIL_SHOCK_REVERSAL_V1.

Limited contributor. It had 1 open paper position and paper observation flow, but outcome readiness remained blocked by close condition not met.

## Unlikely Near-Term Contributors

- C2_DEFENSIVE_TAIL_V1: no candidate flow, no observation flow, no paper path, and REDESIGN status.
- C2_INTENT_SIMULATOR_V1: no candidate flow, no observation flow, no paper path, and REDESIGN status.
- C2_MARKET_NEUTRAL_SPREAD_V1: no candidate flow, no observation flow, no paper path, and REDESIGN status.
- C2_EVENT_DISLOCATION_V1: high candidate count in related hypothesis evidence, but 0 paper positions and 0 usable validation samples.
- ehp_macro_calendar_fixture: NEEDS_DATA, NO_DATA_SOURCE, and DATA_QUALITY_BLOCKED.

## Limiting Factor Assessment

Time: PRIMARY LIMITER.

Most existing positions are open, and most trend-equity positions are not near deterministic closure.

Candidate conversion: SECONDARY LIMITER.

It prevents non-trend sleeves and hypotheses from adding paper observations and validation samples.

Paper-position depth: SECONDARY LIMITER.

Trend-equity has depth; most other sleeves do not. This limits distributed evidence maturity.

Data blockers: INTERMITTENT LIMITER.

Data and authority issues can interrupt interpretation, especially shown by 2026-06-04 missing paper_position_events authority, but they are not the main reason 2026-06-03 trend-equity positions remained open.

Sleeve inactivity: SELECTIVE LIMITER.

It matters for REDESIGN and NEEDS_DATA sleeves, but not for the active trend-equity outcome stream.

## Recommended Next Action

Run a read-only evidence refresh after the next deterministic outcome cycle and compare three numbers:

1. Included validation samples for HYP_LARGE_CAP_EQUITY_MOMENTUM_20_60D_V1 / C2_TREND_EQ_PRIMARY_V1.
2. First closed samples from paper-active zero-sample sleeves.
3. Count of trend-equity open positions still near deterministic closure thresholds.

The next evidence check should determine whether the conservative forecast of 0 to 2 near-term additional samples was accurate, and whether sample accumulation remains concentrated in C2_TREND_EQ_PRIMARY_V1.

Do not change exit rules, sleeve behavior, candidate generation, validation schemas, governance, architecture, runtime truth logic, or capital allocation.
